Advertisement

Topics

Ligand Appoints Dr. Nancy Gray to its Board of Directors

09:00 EDT 21 Aug 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) (“Ligand” or “the Company”) announces the appointment of Nancy Ryan Gray, Ph.D. to the Company’s Board of Directors, effective today. Dr. Gray currently serves as Pres...

Other Sources for this Article

Ligand Pharmaceuticals Incorporated
Todd Pettingill
investors@ligand.com
(858) 550-7500
@Ligand_LGND
or
LHA
Bruce Voss
bvoss@lhai.com
(310) 691-7100

NEXT ARTICLE

More From BioPortfolio on "Ligand Appoints Dr. Nancy Gray to its Board of Directors"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Acute Coronary Syndromes ACS
Acute Coronary Syndromes (ACS) is an umbrella term for situations where the blood supplied to the heart muscle is suddenly blocked. Treatment for acute coronary syndrome includes medicines and a procedure known as angioplasty, during which doctors inflat...